STOCK TITAN

Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings date

Bio-Techne (NASDAQ: TECH) will host a conference call and webcast on Wednesday, May 6, 2026 at 8:00 a.m. CDT to review third quarter fiscal 2026 financial results.

Access details include U.S. and international dial-in numbers, conference ID TECHQ3, and a live webcast at the company investor site. A recorded replay will run from 11:00 a.m. CDT May 6 until 11:00 p.m. CDT June 6, 2026.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • None.

Negative

  • None.

News Market Reaction – TECH

+1.96%
1 alert
+1.96% News Effect

On the day this news was published, TECH gained 1.96%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference call time: 8:00 a.m. CDT Conference call date: May 6, 2026 Domestic dial-in: 1-800-343-4136 +5 more
8 metrics
Conference call time 8:00 a.m. CDT Start time for Q3 FY26 results call on May 6, 2026
Conference call date May 6, 2026 Date of Q3 FY26 earnings conference call
Domestic dial-in 1-800-343-4136 U.S. access number for live conference call
International dial-in 1-203-518-9843 International access number for live conference call
Replay start 11:00 a.m. CDT, May 6, 2026 Replay availability start time
Replay end 11:00 p.m. CDT, June 6, 2026 Replay availability end time
Replay domestic dial-in 1-844-512-2921 U.S. access number for recorded rebroadcast
Replay international dial-in 1-412-317-6671 International access number for recorded rebroadcast

Market Reality Check

Price: $48.21 Vol: Volume 1,847,124 is below...
normal vol
$48.21 Last Close
Volume Volume 1,847,124 is below 20-day average of 2,079,213 (relative volume 0.89). normal
Technical Price 57.53 is trading slightly below 200-day MA at 57.86, and 20.27% below 52-week high.

Peers on Argus

Peer momentum scanner only flagged HALO moving down ~3% with no news. Other key ...
1 Down

Peer momentum scanner only flagged HALO moving down ~3% with no news. Other key peers showed mixed, smaller moves, and the target’s direction was not captured, pointing to stock-specific dynamics.

Previous Conferences,earnings date Reports

1 past event · Latest: Jan 20 (Neutral)
Same Type Pattern 1 events
Date Event Sentiment Move Catalyst
Jan 20 Earnings call date Neutral +1.3% Announced timing and access details for Q2 FY26 earnings conference call.
Pattern Detected

Prior earnings-date conference-call announcements saw a modest positive move of about 1.3% the next day.

Recent Company History

In recent months, Bio-Techne combined operational updates with regular investor communications. A prior earnings-date conference call announcement on Jan 20, 2026 led to a 1.3% gain over 24 hours. Other news included spatial biology product expansions, CE‑IVD marking for the Ella platform, leadership changes, and a dividend alongside over $1.2 billion in fiscal 2025 net sales. Today’s scheduling of the Q3 FY26 call continues this pattern of consistent quarterly disclosures.

Historical Comparison

+1.3% avg move · Prior earnings-date call news produced an average 1.3% move. Today’s similar Q3 FY26 call notice fit...
conferences,earnings date
+1.3%
Average Historical Move conferences,earnings date

Prior earnings-date call news produced an average 1.3% move. Today’s similar Q3 FY26 call notice fits this established pattern of modest reactions.

The company has maintained a consistent cadence of quarterly earnings calls, providing timing and access details ahead of results.

Market Pulse Summary

This announcement sets the date and access details for Bio-Techne’s Q3 fiscal 2026 earnings call at ...
Analysis

This announcement sets the date and access details for Bio-Techne’s Q3 fiscal 2026 earnings call at 8:00 a.m. CDT on May 6, 2026. It follows a consistent pattern of quarterly disclosures, including a prior earnings-date notice that coincided with a 1.3% move. Investors often pair such logistics updates with recent filings and prior quarterly trends to frame expectations, then focus on the forthcoming revenue, margin, and cash-flow details once results are released.

AI-generated analysis. Not financial advice.

MINNEAPOLIS, April 14, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 6, 2026, at 8:00 a.m. CDT to review its third quarter fiscal 2026 financial results.

Access to the discussion may be obtained as follows:

Time:

8:00 a.m. CDT

Date:

May 6, 2026

Dial-in:

1-800-343-4136 or 1-203-518-9843 (for international callers)

Conference ID:

TECHQ3

Webcast:

https://investors.bio-techne.com/ir-calendar

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 11161556.

The replay will be available from 11:00 a.m. CDT on Wednesday, May 6, 2026, until 11:00 p.m. CDT on Saturday, June 6, 2026.

About Bio-Techne

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at LinkedIn, X, or YouTube.

Contact:

David Clair, Vice President, Investor Relations

david.clair@bio-techne.com

612-656-4416

 

BT Logo (PRNewsfoto/Bio-Techne Corporation)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-may-6-2026-to-announce-third-quarter-fiscal-2026-financial-results-302741254.html

SOURCE Bio-Techne Corporation

FAQ

When will Bio-Techne (TECH) announce third quarter fiscal 2026 results?

Bio-Techne will announce Q3 fiscal 2026 results on May 6, 2026 with a management call at 8:00 a.m. CDT. According to the company, management will review financial results and take questions during the live webcast and dial-in conference.

How can investors join the Bio-Techne (TECH) May 6, 2026 earnings call?

Investors can join the call by dialing 1-800-343-4136 or international 1-203-518-9843 with conference ID TECHQ3. According to the company, a live webcast will also be available on the investor relations site.

Where will the Bio-Techne (TECH) webcast be hosted for the May 6, 2026 call?

The webcast will be hosted on the company's investor relations website at investors.bio-techne.com/ir-calendar. According to the company, the live webcast will stream the management discussion and Q&A for third quarter fiscal 2026.

Is a replay available for the Bio-Techne (TECH) May 6, 2026 conference call?

Yes. A recorded rebroadcast will be available from 11:00 a.m. CDT on May 6, 2026 until 11:00 p.m. CDT on June 6, 2026. According to the company, replay dial-in numbers and a replay conference ID are provided for access.

What conference ID should participants use for the Bio-Techne (TECH) May 6, 2026 live call?

Participants should use conference ID TECHQ3 to access the live May 6, 2026 call at 8:00 a.m. CDT. According to the company, that ID applies to the live dial-in session; the replay uses a separate reference number.

What times should global investors note for the Bio-Techne (TECH) May 6, 2026 event?

The live call begins at 8:00 a.m. CDT on May 6, 2026, with replay available from 11:00 a.m. CDT May 6 through 11:00 p.m. CDT June 6, 2026. According to the company, international dial-in numbers are provided for global participants.